| Dr Rakhi Goel, MD | |
|
5645 Main St, Dept Of Radiology, Flushing, NY 11355 | |
| (718) 670-1888 | |
| Not Available |
| Full Name | Dr Rakhi Goel |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 19 Years |
| Location | 5645 Main St, Flushing, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114051562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | D66151 (Maryland) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 301580-01 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian/queens | Flushing, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Street Radiology At Bayside Llc | 5395732671 | 45 |
| Radiology Of Main Street Pc | 5799677522 | 45 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
| Entity Name | North Shore Hematology Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396794574 PECOS PAC ID: 1456243641 Enrollment ID: O20040324001766 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
| Entity Name | Main Street Radiology At Bayside Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780771634 PECOS PAC ID: 5395732671 Enrollment ID: O20040428001019 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
| Entity Name | Radiology Of Main Street Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265529101 PECOS PAC ID: 5799677522 Enrollment ID: O20040824000320 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
| Entity Name | Sunset Park Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629713672 PECOS PAC ID: 6608247291 Enrollment ID: O20230118001304 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rakhi Goel, MD 5645 Main St, Department Of Radiology, Flushing, NY 11355 Ph: (718) 670-1888 | Dr Rakhi Goel, MD 5645 Main St, Dept Of Radiology, Flushing, NY 11355 Ph: (718) 670-1888 |
News Archive
Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Male students in undergraduate introductory biology courses are outperforming females at test time, but it may be due to how exams are designed rather than academic ability.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.
MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.
› Verified 7 days ago
Kiran Chawla, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5447 Fax: 718-670-3039 | |
Dr. David J. Axelrod, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 17660 Union Tpke Ste 130, Flushing, NY 11366 Phone: 718-820-9729 Fax: 718-820-9730 | |
Dr. John P Derosa, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1594 Fax: 718-670-1901 | |
Dr. Jeffrey C Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1594 Fax: 718-670-1901 | |
Lia Bartella, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 170-17 Northern Blvd, Flushing, NY 11358 Phone: 646-637-8331 Fax: 718-539-4021 | |
Dr. Han Kim, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1594 Fax: 718-670-1901 |